Literature DB >> 23032261

B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).

Eugen Werwein1, Thore Schmedt, Heiko Hoffmann, Clemens Usadel, Nora Obermann, Jeffrey D Singer, Karl-Heinz Klempnauer.   

Abstract

B-Myb is a highly conserved member of the Myb transcription factor family, which plays an essential role in cell cycle progression by regulating the transcription of genes at the G 2/M-phase boundary. The role of B-Myb in other parts of the cell cycle is less well-understood. By employing siRNA-mediated silencing of B-Myb expression, we found that B-Myb is required for efficient entry into S-phase. Surprisingly, a B-Myb mutant that lacks sequence-specific DNA-binding activity and is unable to activate transcription of B-Myb target genes is able to rescue the S-phase defect observed after B-Myb knockdown. Moreover, we have identified polymerase delta-interacting protein 1 (Pdip1), a BTB domain protein known to bind to the DNA replication and repair factor PCNA as a novel B-Myb interaction partner. We have shown that Pdip1 is able to interact with B-Myb and PCNA simultaneously. In addition, we found that a fraction of endogenous B-Myb can be co-precipitated via PCNA, suggesting that B-Myb might be involved in processes related to DNA replication or repair. Taken together, our work suggests a novel role for B-Myb in S-phase that appears to be independent of its sequence-specific DNA-binding activity and its ability to stimulate the expression of bona fide B-Myb target genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23032261      PMCID: PMC3507500          DOI: 10.4161/cc.22386

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  60 in total

1.  Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner.

Authors:  T Krude
Journal:  Exp Cell Res       Date:  1999-02-25       Impact factor: 3.905

2.  E2Fs link the control of G1/S and G2/M transcription.

Authors:  Wencheng Zhu; Paloma H Giangrande; Joseph R Nevins
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

3.  Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle.

Authors:  C Robinson; Y Light; R Groves; D Mann; R Marias; R Watson
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

4.  Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression.

Authors:  P B McIntosh; T A Frenkiel; U Wollborn; J E McCormick; K H Klempnauer; J Feeney; M D Carr
Journal:  Biochemistry       Date:  1998-07-07       Impact factor: 3.162

5.  B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.

Authors:  S Lane; P Farlie; R Watson
Journal:  Oncogene       Date:  1997-05-22       Impact factor: 9.867

6.  Activation of human B-MYB by cyclins.

Authors:  A Sala; M Kundu; I Casella; A Engelhard; B Calabretta; L Grasso; M G Paggi; A Giordano; R J Watson; K Khalili; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

7.  Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.

Authors:  O Bartsch; S Horstmann; K Toprak; K H Klempnauer; S Ferrari
Journal:  Eur J Biochem       Date:  1999-03

8.  B-myb is required for inner cell mass formation at an early stage of development.

Authors:  Y Tanaka; N P Patestos; T Maekawa; S Ishii
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

9.  Drosophila myb is required for the G2/M transition and maintenance of diploidy.

Authors:  A L Katzen; J Jackson; B P Harmon; S M Fung; G Ramsay; J M Bishop
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

10.  The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.

Authors:  M K Saville; R J Watson
Journal:  Oncogene       Date:  1998-11-26       Impact factor: 9.867

View more
  10 in total

1.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

2.  PDIP38 is translocated to the spliceosomes/nuclear speckles in response to UV-induced DNA damage and is required for UV-induced alternative splicing of MDM2.

Authors:  Agnes Wong; Sufang Zhang; Dana Mordue; Joseph M Wu; Zhongtao Zhang; Zbigniew Darzynkiewicz; Ernest Y C Lee; Marietta Y W T Lee
Journal:  Cell Cycle       Date:  2013-09-03       Impact factor: 4.534

3.  Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3β implicate human B-Myb in DNA-damage signaling.

Authors:  Sarah Marie Henrich; Clemens Usadel; Eugen Werwein; Kamila Burdova; Pavel Janscak; Stefano Ferrari; Daniel Hess; Karl-Heinz Klempnauer
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

4.  NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer.

Authors:  Szymon J Szymura; Jacob P Zaemes; David F Allison; Sheena H Clift; Jaclyn M D'Innocenzi; Lisa G Gray; Brian D McKenna; Benjamin B Morris; Stefan Bekiranov; Robin D LeGallo; David R Jones; Marty W Mayo
Journal:  Cell Commun Signal       Date:  2019-03-18       Impact factor: 5.712

5.  Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization.

Authors:  Eugen Werwein; Hannah Cibis; Daniel Hess; Karl-Heinz Klempnauer
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

6.  Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins.

Authors:  Hannah Cibis; Abhiruchi Biyanee; Wolfgang Dörner; Henning D Mootz; Karl-Heinz Klempnauer
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

7.  The Dm-Myb Oncoprotein Contributes to Insulator Function and Stabilizes Repressive H3K27me3 PcG Domains.

Authors:  Juan F Santana; Mrutyunjaya Parida; Abby Long; Joshua Wankum; Anthony J Lilienthal; Krishna M Nukala; J Robert Manak
Journal:  Cell Rep       Date:  2020-03-10       Impact factor: 9.423

8.  A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.

Authors:  Qian Liu; Lijuan Guo; Hongyan Qi; Meng Lou; Rui Wang; Boning Hai; Kailun Xu; Lijun Zhu; Yongfeng Ding; Chen Li; Lingdan Xie; Jing Shen; Xueping Xiang; Jimin Shao
Journal:  Cell Death Dis       Date:  2021-07-07       Impact factor: 8.469

9.  B-Myb switches from Cyclin/Cdk-dependent to Jnk- and p38 kinase-dependent phosphorylation and associates with SC35 bodies after UV stress.

Authors:  E Werwein; M Dzuganova; C Usadel; K-H Klempnauer
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

10.  Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.

Authors:  Marco Gründl; Susanne Walz; Laura Hauf; Melissa Schwab; Kerstin Marcela Werner; Susanne Spahr; Clemens Schulte; Hans Michael Maric; Carsten P Ade; Stefan Gaubatz
Journal:  PLoS Genet       Date:  2020-05-29       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.